Infectious disease

Infectious disease testing and diagnosis is the process of identifying and confirming pathogens, which is crucial for controlling the spread of diseases. It includes clinical symptom assessment, laboratory tests (such as blood, urine, and sputum analysis), among others. Accurate diagnosis aids in timely treatment, prevents the spread of epidemics, and protects public health. Additionally, it helps understand the epidemiological trends of diseases, guiding vaccine development and public health policy formulation. Therefore, infectious disease testing and diagnosis hold significant importance in the fields of medicine and public health.


HIV - P24

When the HIV virus invades the human body, it stimulates the immune system to produce specific HIV antigens. HIV antibody testing, also known as serological testing, is a routine method for assessing the presence of HIV antibodies in an individual's blood. Commonly used HIV antibody testing techniques include Enzyme-Linked Immunosorbent Assay (ELISA), chemiluminescent immunoassay, immunofluorescence assay, and immunochromatographic tests.

View more
PairLotProduct nameClassesMethodAdvantageApplicationOn Trial
Pairing 1 HIV21 HIV-1 p24 antibody Ab HIV double antibody sandwich method Package
Pairing 1 HIV22 HIV-1 p24 antibody Ab HIV double antibody sandwich method Mark

Syphilis (TP)

Syphilis is a chronic and systemic sexually transmitted disease caused by the pale spirochete (i.e., Treponema pallidum), primarily transmitted through sexual contact. Syphilis can be divided into different stages, including primary, secondary, tertiary, latent syphilis, and congenital syphilis (also known as fetal transmission syphilis). This disease is unique to humans, and both symptomatic and asymptomatic patients can transmit it. Syphilis patients have the spirochete present in their skin lesions, secretions, and blood. Additionally, the spirochete can be transmitted to the fetus through the placenta, and the risk of transmitting syphilis to the fetus is higher for pregnant women in the early stages of the disease.

View more
PairLotProduct nameClassesMethodAdvantageApplicationOn Trial
[object Object] Pairing 1 TP11 TP 15KD+17KD+47KD antigen Ag TP double antigen sandwich method Package
[object Object] Pairing 1 TP12 TP 15KD+17KD+47KD antigen Ag TP double antigen sandwich method Mark
Pairing 2 TP12 TP 15KD+17KD+47KD antigen Ag TP double antigen sandwich method Mark
Pairing 2 TP112 TP 15KD+17KD+47KD antigen Ag TP double antigen sandwich method Package

Hepatitis B (HBV) - sAg

HBsAg is a marker of HBV infection, indicating the presence of the virus. Quantitative detection monitors changes in the condition and is strongly positively correlated with HBV DNA. The level of HBsAg reflects viral replication and infectivity. In HBeAg positive carriers, high levels of HBsAg and HBV DNA indicate active replication. HBsAg testing is used for diagnosis, monitoring disease progression, assessing treatment response, and evaluating the efficacy of new drugs.

View more
PairLotProduct nameClassesMethodAdvantageApplicationOn Trial
Five companies joint packaging HBV22 HBV sAg antibody Ab HBV sAg double antibody sandwich method Package
Five companies joint packaging HBV23 HBV sAg antibody Ab HBV sAg double antibody sandwich method Package
Five companies joint packaging HBV24 HBV sAg antibody Ab HBV sAg double antibody sandwich method Package
Five companies joint packaging HBV27 HBV sAg antibody Ab HBV sAg double antibody sandwich method Package
Five companies joint packaging HBV281 HBV sAg antibody Ab HBV sAg double antibody sandwich method Package

Hepatitis B (HBV) - core Ab

HBcAb is a specific antibody produced against HBcAg. After HBV infection, the human body produces IgM and IgG. IgM appears in the early stages of infection and is used to diagnose acute hepatitis B. During the chronic phase, IgM disappears, and HBcAb remains in the blood. Testing for HBcAb helps in diagnosing chronic hepatitis B.

View more
PairLotProduct nameClassesMethodAdvantageApplicationOn Trial
Pairing 1 HBV12 HBV core antibody Ag HBV cAb competitive assay Package
Pairing 1 HBV29 HBV core antibody Ab HBV cAb competitive assay Mark

Hepatitis B (HBV) - PreS1

The PreS1 antigen is located on the surface of Dane particles and tubular particles, exhibiting hydrophilicity and immunogenicity. Its peptide segment 21-47 is a key binding site for HBV to liver cells, which is crucial for HBV attachment and invasion of liver cells. The presence of PreS1 antigen in serum indicates the presence of HBV. It is only found in infectious HBV particles and is highly consistent with HBV-DNA and HBeAg tests, making it a useful supplementary test. PreS1 antigen testing helps assess the prognosis of hepatitis B and the efficacy of treatment, especially in HBeAg-negative patients, where high levels of PreS1 antigen may suggest the need for antiviral therapy.

View more
PairLotProduct nameClassesMethodAdvantageApplicationOn Trial
Pairing HBV29 HBV preS1 antibody Ab HBV preS1 double antibody sandwich method Package
Pairing HBV210 HBV preS1 antibody Ab HBV preS1 double antibody sandwich method Mark

Hepatitis B (HBV) - eAg

HBeAg is a part of the HBV core antigen and reflects the activity of viral replication. A positive result indicates active HBV replication and high infectivity. The disappearance of HBeAg and the appearance of anti-HBe usually indicate an improvement in the condition, but it does not necessarily mean non-infectivity. In acute hepatitis B, HBeAg may be briefly positive, and persistent positivity may progress to chronic infection. HBeAg testing is used for diagnosing HBV infection, monitoring disease progression, assessing treatment effectiveness, and evaluating the efficacy of new drugs.

View more
PairLotProduct nameClassesMethodAdvantageApplicationOn Trial
Pairing 1 HBV211 HBV eAg antibody Ab HBV eAg double antibody sandwich method Package
Pairing 1 HBV212 HBV eAg antibody Ab HBV eAg double antibody sandwich method Mark

Hepatitis C (HCV)

Hepatitis C, abbreviated as HCV, is a viral liver disease caused by the hepatitis C virus (HCV). This disease is primarily transmitted through blood transfusions, needle injuries, and drug abuse.

View more
PairLotProduct nameClassesMethodAdvantageApplicationOn Trial
Pairing 1 HCV12 HCV-1 CORE+NS3 antigen Ag / Package
Pairing 1 HCV13 HCV-1 CORE+NS3 antigen Ag / Mark

Hand-foot-and-mouth disease (EV71) - IgM

The EV71 type virus of hand, foot, and mouth disease is an infectious disease caused by enteroviruses. This disease primarily affects infants and young children, but adults can also be at risk of infection.

View more
PairLotProduct nameClassesMethodAdvantageApplicationOn Trial
/ EV71-22 EV71 antigen Ab EV71 IgM capture method First Mark
/ EV71-22 EV71 antibody Ab EV71 IgM capture method Second Mark

EB virus (EBV) - IgA

The Epstein-Barr virus (EBV) is a DNA virus that belongs to the herpesvirus family, characterized by its biological property of specifically infecting human and certain primate B cells both in vivo and in vitro. Laboratory testing for EBV mainly includes the detection of different targets such as EBNA1, VCA, and ZTA.

View more
PairLotProduct nameClassesMethodAdvantageApplicationOn Trial
/ EBV11 EBV EBNA1 antigen Ag EBV IgA Indirect Method Package 1
/ EBV12 EBV VCA antigen Ag EBV IgA Indirect Method Package 2
/ EBV13 EBV ZTA antigen Ag EBV IgA Indirect Method Package 3

Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV) is an RNA virus belonging to the Paramyxoviridae family and is one of the main pathogens causing lower respiratory tract infections in infants and young children. The RSV viral particles consist of a nucleocapsid enveloped in a double lipid layer derived from the host membrane, containing fusion proteins (F) among others. The RSV genome is composed of single-stranded negative-sense RNA with 10 open reading frames (ORFs), encoding 11 structural and non-structural proteins.

View more
PairLotProduct nameClassesMethodAdvantageApplicationOn Trial
Pairing RSV23 RSV antibody Ab RSV double antibody sandwich method Mark
Pairing RSV22 RSV antibody Ab RSV double antibody sandwich method Package

Novel Coronavirus (2019-nCoV)

The N protein is highly conserved among different SARS-CoV-2 strains and has good immunogenicity. It is the structural protein expressed at the highest levels after the virus infects cells. The N protein is relatively more stable and has higher immunogenicity compared to the S protein. Therefore, the N protein is a necessary complement for nucleic acid testing of the novel coronavirus and serves as a good biomarker for detection. Our company's raw materials can specifically and efficiently detect N protein antigens, with strong interference resistance and stable batch-to-batch consistency.

View more
PairLotProduct nameClassesMethodAdvantageApplicationOn Trial
Pairing 1 nCoV-N-28 2019 novel coronavirus (nCoV) N antibody Ab 2019-nCoV double antibody sandwich method Mark
Pairing 1 nCoV-N-27 2019 novel coronavirus (nCoV) N antibody Ab 2019-nCoV double antibody sandwich method Package
< 1 > proceed page